CD8A and Hepatitis: The number of tLymph cells, CD8+ T lymphocytes, and B lymphocytes in the peripheral blood of OBI patients of the treatment group after 36 weeks of hepatitis B vaccine treatment were significantly increased and positively correlated with the levels of anti-HBs.